Form 4: Hims & Hers Director Christopher Payne Reports Vesting and Acquisition of Class A Common Stock
Insider Transaction Report
Hims & Hers Health, Inc. Director Christopher D. Payne reported the acquisition of 19,975 shares of Class A Common Stock through the vesting and conversion of Restricted Stock Units on June 12 and June 13, 2025.
Summary
- Christopher D. Payne, a Director of Hims & Hers Health, Inc., reported transactions involving the acquisition of Class A Common Stock.
- On June 12, 2025, 9,935 shares of Class A Common Stock were acquired through the conversion of Restricted Stock Units (RSUs). These RSUs were set to vest on the earlier of the 2025 annual meeting of stockholders or June 15, 2025.
- On June 13, 2025, an additional 10,040 shares of Class A Common Stock were acquired from the conversion of RSUs. These RSUs are part of a 3-year service-based vesting schedule, with 1/3 vesting on June 15, 2025, 1/3 on June 15, 2026, and 1/3 on June 15, 2027.
- Following these transactions, Mr. Payne directly beneficially owns 19,975 shares of Class A Common Stock.
- Additionally, 110,000 shares of Class A Common Stock are indirectly beneficially owned by Mr. Payne through The Payne Family Trust dated September 17, 2020.
Sentiment
Score: 5
Explanation: Neutral. This is a routine insider transaction report (Form 4) detailing the vesting and conversion of Restricted Stock Units, which is a standard part of executive compensation. It does not contain information that would typically indicate positive or negative sentiment regarding the company's performance or outlook.
Positives
- Director Christopher D. Payne increased his direct beneficial ownership of Class A Common Stock by 19,975 shares through the vesting of Restricted Stock Units, indicating continued alignment with shareholder interests.
Future Outlook
The document outlines future vesting dates for Restricted Stock Units on June 15, 2026, and June 15, 2027, indicating a continued long-term equity compensation structure for the reporting person.
Industry Context
This Form 4 filing is a standard disclosure of insider equity transactions, common across all publicly traded companies. It reflects a routine compensation event for a director, rather than a strategic business announcement or a reflection of broader industry trends.
Related Party Transactions
- The indirect beneficial ownership of 110,000 shares of Class A Common Stock by The Payne Family Trust dtd 09/17/2020 represents a related party holding.
Stakeholder Impact
- Shareholders: The increase in direct beneficial ownership by a director may be viewed as a positive signal of continued alignment of interests between management and shareholders.
- Employees: No direct impact on employees beyond the reporting person's compensation structure.
Next Steps
- Future vesting of 1/3 of the 10,040 RSUs on June 15, 2026.
- Future vesting of the final 1/3 of the 10,040 RSUs on June 15, 2027.
Key Dates
| Date | Description |
|---|---|
| 2020-09-17 | Date of The Payne Family Trust, which indirectly holds 110,000 shares of Class A Common Stock. |
| 2025-06-12 | Transaction date for the acquisition of 9,935 Class A Common Stock shares from RSU conversion. |
| 2025-06-13 | Transaction date for the acquisition of 10,040 Class A Common Stock shares from RSU conversion. |
| 2025-06-15 | Vesting date for 9,935 RSUs (earlier of 2025 annual meeting or this date) and the first 1/3 vesting date for 10,040 RSUs. |
| 2025-06-16 | Date the Form 4 was signed by Alexandra Cotter Wilkins, Attorney-in-Fact. |
| 2026-06-15 | Second 1/3 vesting date for 10,040 RSUs. |
| 2027-06-15 | Third 1/3 vesting date for 10,040 RSUs. |
Keywords
Hims & Hers Health Inc., HIMS, SEC Form 4, Insider Trading, Stock Ownership, Restricted Stock Units, RSU Vesting, Director Compensation, Equity Compensation, Christopher D. Payne
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.